Meta-analysis of tau genetic polymorphism and sporadic progressive supranuclear palsy susceptibility

Neural Regeneration Research

Volumn 6, Issue 5, 2011, Pages 353-359

  Yuan, Hai ^a,b   Yang, Xiuyan ^a   Kang, Hanlin ^a   Cheng, Ying ^a   Ren, Huiming ^a   Wang, Xiaotong ^a  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b The Second People's Hospital of Hefei City   (China)

Author keywords

Genes; Meta analysis; Microtubule associated protein tau; Polymorphism; Progressive supranuclear palsy

Indexed keywords

TAU PROTEIN;

ARTICLE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; PROGRESSIVE SUPRANUCLEAR PALSY; SYSTEMATIC REVIEW;

EID: 79952468509     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Burn DJ, Lees AJ. Progressive supranuclear palsy: where are we now? Lancet Neurol. 2002;1(6):359-369.
2. Esper CD, Weiner WJ, Factor SA. Progressive supranuclear palsy. Rev Neurol Dis. 2007;4(4):209-216.
3. Nath U, Burn DJ. The epidemiology of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Parkinsonism Relat Disord. 2000;6(3):145-153.
4. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1-9.
5. Golbe LI. Progressive supranuclear palsy in the molecular age. Lancet. 2000;356(9233):870-871.
6. Zhou J, Yu Q, Zou T. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies. BMC Neurosci. 2008;9 Suppl 2:S10.
7. Goedert M, Spillantini MG, Potier MC, et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 1989;8(2):393-399.
8. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999;8(4):711-715.
9. Shaw-Smith C, Pittman AM, Willatt L, et al. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet. 2006;38(9):1032-1037.
10. Schraen-Maschke S, Dhaenens CM, Delacourte A, et al. Micrtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases. Neurobiol Dis. 2004;15(3):449-460.
11. Stefansson H, Helgason A, Thorleifsson G, et al. Common inversion under selection in Europeans. Nat Genet. 2005;37(2):129-137.
12. Liu WK, Le TV, Adamson J, et al. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol. 2001;50(4):494-502.
13. Robins JS, Greenland S, Breslow NE. A general estimator of the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol. 1986;124(5):719-723.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials.1986;7(3):177-188.
15. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
16. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
17. Pittman AM, Myers AJ, Duckworth J, et al. The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum Mol Genet. 2004;13(12):1267-1274.
18. Hoenicka J, Pérez M, Pérez-Tur J, et al. The tau gene A0 allele and progressive supranuclear palsy. Neurology. 1999;53(6):1219-1225.
19. Pittman AM, Myers AJ, Abou-Sleiman P, et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet. 2005;42(11):837-846.
20. Ezquerra M, Pastor P, Valldeoriola F, et al. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans. Neurosci Lett. 1999;275(3):183-186.
21. Morris HR, Schrag A, Nath U, et al. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Neurosci Lett. 2001;312(2):118-120.
22. Molinuevo JL, Valldeoriola F, Alegret M, et al. Progressive supranuclear palsy: earlier age of onset in patients with the tau protein A0/A0 genotype. J Neurol. 2000;247(3):206-208.
23. Baba Y, Putzke JD, Tsuboi Y, et al. Effect of MAPT and APOE on prognosis of progressive supranuclear palsy. Neurosci Lett. 2006;405(1-2):116-119.
24. Webb A, Miller B, Bonasera S, et al. Role of the Tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders. Arch Neurol. 2008;65(11):1473-1478.
25. Higgins JJ, Litvan I, Pho LT, et al. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the a-synuclein gene. Neurology. 1998;50(1):270-273.
26. Bennett P, Bonifati V, Bonuccelli U, et al. Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. Neurology. 1998;51(4):982-985.
27. Oliva R, Tolosa E, Ezquerra M, et al. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch Neurol.1998;55(8):1122-1124.
28. Rademakers R, Melquist S, Cruts M, et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet. 2005;14(21):3281-3292.
29. Ezquerra M, Gaig C, Ascaso C, et al. Tau and saitohin gene expression pattern in progressive supranuclear palsy. Brain Res. 2007;1145:168-176.
30. Ros R, Ampuero I, García de Yébenes J. Parkin polymorphisms in progressive supranuclear palsy. J Neurol Sci. 2008;268(1-2):176-178.
31. Litvan I, Baker M, Hutton M. Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy. Neurology. 2001;57(1):138-140.
32. de Silva R, Weiler M, Morris HR, et al. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. Neurosci Lett. 2001;311(3):145-148.
33. Pastor P, Ezquerra M, Tolosa E, et al. Further extension of the H1 haplotype associated with progressive supranuclear palsy. Mov Disord. 2002;17(3):550-556.
34. Morris HR, Janssen JC, Bandmann O, et al. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 1999;66(5):665-667.
35. Panegyres PK, Zafiris-Toufexis K. Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. Eur J Neurol. 2002;9(5):485-489.
36. Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol. 1997;41(2):277-281.
37. Togo T, Sahara N, Yen SH, et al. Argyrophilic grain disease is a sporadic 4-repeat taupathy. J Neuropathol Exp Neurol. 2002;61(6):547-556.
38. Conrad C, Amano N, Andreadis A, et al. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy. Neurosci Lett. 1998;250(2):135-137.